Krystal Biotech Insider Trades
NASDAQ: KRYSHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 0 · $0
- Sales
- 81 · $58.75M
- Shares bought / sold
- 0 / 189.19K
- Net activity
- Net selling $58.8 million
Krystal Biotech insider activity
Over the last 12 months, Krystal Biotech insiders reported 100 transactions on SEC Form 4: 0 open-market purchases and 81 sales. Insiders bought $0 and sold $58.8 million worth of stock, for net insider selling of $58.8 million. The largest seller was Krishnan Suma, with $23.3 million in reported sales.
The most recent filing shows Krishnan Suma (President, R&D) selling 520 shares at $354.54 on Sep 4, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put KRYS's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
KRYS insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Sep 4, 2026 | Krishnan Krish SPresident and CEO | Sale | 405 | $148.46K | Form 4 |
| Sep 4, 2026 | Krishnan Krish SPresident and CEO | Sale | 847 | $309.51K | Form 4 |
| Sep 4, 2026 | Krishnan Krish SPresident and CEO | Sale | 1,358 | $494.96K | Form 4 |
| Sep 4, 2026 | Krishnan Krish SPresident and CEO | Sale | 573 | $208.20K | Form 4 |
| Sep 4, 2026 | Krishnan Krish SPresident and CEO | Sale | 2,010 | $728.93K | Form 4 |
| Sep 4, 2026 | Krishnan Krish SPresident and CEO | Sale | 1,214 | $438.99K | Form 4 |
| Sep 4, 2026 | Krishnan Krish SPresident and CEO | Sale | 2,266 | $816.81K | Form 4 |
| Sep 4, 2026 | Krishnan Krish SPresident and CEO | Sale | 3,357 | $1.21M | Form 4 |
| Sep 4, 2026 | Krishnan Krish SPresident and CEO | Sale | 3,143 | $1.13M | Form 4 |
| Sep 4, 2026 | Krishnan Krish SPresident and CEO | Sale | 3,981 | $1.42M | Form 4 |
| Sep 4, 2026 | Krishnan Krish SPresident and CEO | Sale | 3,297 | $1.17M | Form 4 |
| Sep 4, 2026 | Krishnan Krish SPresident and CEO | Sale | 2,029 | $721.46K | Form 4 |
| Sep 4, 2026 | Krishnan Krish SPresident and CEO | Sale | 520 | $184.36K | Form 4 |
| Sep 4, 2026 | Krishnan SumaPresident, R&D | Sale | 399 | $146.26K | Form 4 |
| Sep 4, 2026 | Krishnan SumaPresident, R&D | Sale | 826 | $301.83K | Form 4 |
| Sep 4, 2026 | Krishnan SumaPresident, R&D | Sale | 1,329 | $484.39K | Form 4 |
| Sep 4, 2026 | Krishnan SumaPresident, R&D | Sale | 565 | $205.29K | Form 4 |
| Sep 4, 2026 | Krishnan SumaPresident, R&D | Sale | 1,992 | $722.40K | Form 4 |
| Sep 4, 2026 | Krishnan SumaPresident, R&D | Sale | 1,242 | $449.12K | Form 4 |
| Sep 4, 2026 | Krishnan SumaPresident, R&D | Sale | 2,320 | $836.28K | Form 4 |
| Sep 4, 2026 | Krishnan SumaPresident, R&D | Sale | 3,392 | $1.22M | Form 4 |
| Sep 4, 2026 | Krishnan SumaPresident, R&D | Sale | 3,180 | $1.14M | Form 4 |
| Sep 4, 2026 | Krishnan SumaPresident, R&D | Sale | 3,962 | $1.42M | Form 4 |
| Sep 4, 2026 | Krishnan SumaPresident, R&D | Sale | 3,267 | $1.16M | Form 4 |
| Sep 4, 2026 | Krishnan SumaPresident, R&D | Sale | 2,006 | $713.28K | Form 4 |
| Sep 4, 2026 | Krishnan SumaPresident, R&D | Sale | 520 | $184.36K | Form 4 |
| Aug 14, 2026 | ROSSI DINO ADirector | Sale | 40 | $13.33K | Form 4 |
| Aug 14, 2026 | ROSSI DINO ADirector | Sale | 3,095 | $1.03M | Form 4 |
| Aug 14, 2026 | ROSSI DINO ADirector | Sale | 4,896 | $1.62M | Form 4 |
| Aug 14, 2026 | ROSSI DINO ADirector | Sale | 7,428 | $2.45M | Form 4 |
| Aug 14, 2026 | ROSSI DINO ADirector | Sale | 1,687 | $554.21K | Form 4 |
| Aug 14, 2026 | ROSSI DINO ADirector | Sale | 5,226 | $1.71M | Form 4 |
| Aug 14, 2026 | ROSSI DINO ADirector | Sale | 2,287 | $746.94K | Form 4 |
| Aug 14, 2026 | ROSSI DINO ADirector | Sale | 341 | $111.03K | Form 4 |
| Aug 14, 2026 | ROSSI DINO ADirector | Gift | 3,691 | — | Form 4 |
| Jun 25, 2026 | Thomas John CharlesEVP, General Counsel | Sale | 1,000 | $347.27K | Form 4 |
| Jun 25, 2026 | Thomas John CharlesEVP, General Counsel | Option exercise | 1,000 | $179.25K | Form 4 |
| Jun 4, 2026 | Krishnan Krish SPresident and CEO | Sale | 40 | $12.49K | Form 4 |
| Jun 4, 2026 | Krishnan Krish SPresident and CEO | Sale | 964 | $300.15K | Form 4 |
| Jun 4, 2026 | Krishnan Krish SPresident and CEO | Sale | 2,652 | $823.26K | Form 4 |
| Jun 4, 2026 | Krishnan Krish SPresident and CEO | Sale | 2,784 | $861.62K | Form 4 |
| Jun 4, 2026 | Krishnan Krish SPresident and CEO | Sale | 4,830 | $1.49M | Form 4 |
| Jun 4, 2026 | Krishnan Krish SPresident and CEO | Sale | 11,461 | $3.53M | Form 4 |
| Jun 4, 2026 | Krishnan Krish SPresident and CEO | Sale | 589 | $180.43K | Form 4 |
| Jun 4, 2026 | Krishnan Krish SPresident and CEO | Sale | 544 | $165.82K | Form 4 |
| Jun 4, 2026 | Krishnan Krish SPresident and CEO | Sale | 176 | $53.36K | Form 4 |
| Jun 4, 2026 | Krishnan Krish SPresident and CEO | Sale | 640 | $193.43K | Form 4 |
| Jun 4, 2026 | Krishnan Krish SPresident and CEO | Sale | 320 | $96.24K | Form 4 |
| Jun 4, 2026 | Krishnan SumaPresident, R&D | Sale | 240 | $74.80K | Form 4 |
| Jun 4, 2026 | Krishnan SumaPresident, R&D | Sale | 2,039 | $634.00K | Form 4 |
| Jun 4, 2026 | Krishnan SumaPresident, R&D | Sale | 2,801 | $868.16K | Form 4 |
| Jun 4, 2026 | Krishnan SumaPresident, R&D | Sale | 3,803 | $1.17M | Form 4 |
| Jun 4, 2026 | Krishnan SumaPresident, R&D | Sale | 12,729 | $3.92M | Form 4 |
| Jun 4, 2026 | Krishnan SumaPresident, R&D | Sale | 1,348 | $413.96K | Form 4 |
| Jun 4, 2026 | Krishnan SumaPresident, R&D | Sale | 480 | $146.82K | Form 4 |
| Jun 4, 2026 | Krishnan SumaPresident, R&D | Sale | 400 | $121.96K | Form 4 |
| Jun 4, 2026 | Krishnan SumaPresident, R&D | Sale | 247 | $74.88K | Form 4 |
| Jun 4, 2026 | Krishnan SumaPresident, R&D | Sale | 593 | $179.23K | Form 4 |
| Jun 4, 2026 | Krishnan SumaPresident, R&D | Sale | 320 | $96.24K | Form 4 |
| May 26, 2026 | Thomas John CharlesEVP, General Counsel | Sale | 642 | $193.90K | Form 4 |
| Mar 4, 2026 | Krishnan Krish SPresident and CEO | Sale | 920 | $245.23K | Form 4 |
| Mar 4, 2026 | Krishnan Krish SPresident and CEO | Sale | 2,439 | $647.77K | Form 4 |
| Mar 4, 2026 | Krishnan Krish SPresident and CEO | Sale | 8,798 | $2.33M | Form 4 |
| Mar 4, 2026 | Krishnan Krish SPresident and CEO | Sale | 2,043 | $538.74K | Form 4 |
| Mar 4, 2026 | Krishnan Krish SPresident and CEO | Sale | 2,380 | $624.62K | Form 4 |
| Mar 4, 2026 | Krishnan Krish SPresident and CEO | Sale | 2,962 | $774.29K | Form 4 |
| Mar 4, 2026 | Krishnan Krish SPresident and CEO | Sale | 3,128 | $814.80K | Form 4 |
| Mar 4, 2026 | Krishnan Krish SPresident and CEO | Sale | 1,377 | $357.84K | Form 4 |
| Mar 4, 2026 | Krishnan Krish SPresident and CEO | Sale | 470 | $121.44K | Form 4 |
| Mar 4, 2026 | Krishnan Krish SPresident and CEO | Sale | 483 | $124.28K | Form 4 |
| Mar 4, 2026 | Krishnan SumaPresident, R&D | Sale | 1,700 | $452.92K | Form 4 |
| Mar 4, 2026 | Krishnan SumaPresident, R&D | Sale | 6,000 | $1.59M | Form 4 |
| Mar 4, 2026 | Krishnan SumaPresident, R&D | Sale | 4,852 | $1.28M | Form 4 |
| Mar 4, 2026 | Krishnan SumaPresident, R&D | Sale | 2,248 | $592.53K | Form 4 |
| Mar 4, 2026 | Krishnan SumaPresident, R&D | Sale | 1,938 | $508.43K | Form 4 |
| Mar 4, 2026 | Krishnan SumaPresident, R&D | Sale | 2,931 | $766.20K | Form 4 |
| Mar 4, 2026 | Krishnan SumaPresident, R&D | Sale | 3,667 | $954.76K | Form 4 |
| Mar 4, 2026 | Krishnan SumaPresident, R&D | Sale | 668 | $173.42K | Form 4 |
| Mar 4, 2026 | Krishnan SumaPresident, R&D | Sale | 589 | $152.28K | Form 4 |
| Mar 4, 2026 | Krishnan SumaPresident, R&D | Sale | 407 | $104.73K | Form 4 |
| Mar 2, 2026 | ROMANO KATHRYNChief Accounting Officer | Sale | 750 | $200.70K | Form 4 |
| Feb 27, 2026 | Krishnan SumaPresident, R&D | Option exercise | 4,000 | — | Form 4 |
| Feb 27, 2026 | Krishnan SumaPresident, R&D | Tax withholding | 10,236 | $2.82M | Form 4 |
| Feb 27, 2026 | Krishnan SumaPresident, R&D | Option exercise | 22,500 | — | Form 4 |
| Feb 27, 2026 | Krishnan Krish SPresident and CEO | Tax withholding | 1,820 | $501.66K | Form 4 |
| Feb 27, 2026 | Krishnan Krish SPresident and CEO | Option exercise | 4,000 | — | Form 4 |
| Feb 27, 2026 | Krishnan Krish SPresident and CEO | Tax withholding | 10,236 | $2.82M | Form 4 |
| Feb 27, 2026 | Krishnan Krish SPresident and CEO | Option exercise | 22,500 | — | Form 4 |
| Feb 27, 2026 | Krishnan Krish SPresident and CEO | Tax withholding | 2,605 | $718.04K | Form 4 |
| Feb 27, 2026 | Krishnan Krish SPresident and CEO | Option exercise | 5,725 | — | Form 4 |
| Feb 27, 2026 | Krishnan Krish SPresident and CEO | Tax withholding | 11,942 | $3.29M | Form 4 |
| Feb 27, 2026 | Krishnan Krish SPresident and CEO | Option exercise | 26,250 | — | Form 4 |
| Feb 27, 2026 | Krishnan Krish SPresident and CEO | Tax withholding | 3,981 | $1.10M | Form 4 |
| Feb 27, 2026 | Krishnan Krish SPresident and CEO | Option exercise | 8,750 | — | Form 4 |
| Feb 27, 2026 | ROMANO KATHRYNChief Accounting Officer | Tax withholding | 240 | $66.15K | Form 4 |
| Feb 27, 2026 | ROMANO KATHRYNChief Accounting Officer | Option exercise | 550 | — | Form 4 |
| Feb 27, 2026 | ROMANO KATHRYNChief Accounting Officer | Tax withholding | 3,262 | $899.14K | Form 4 |
| Feb 27, 2026 | ROMANO KATHRYNChief Accounting Officer | Option exercise | 7,500 | — | Form 4 |
| Feb 27, 2026 | JANNEY DANIELDirector | Sale | 2,373 | $655.34K | Form 4 |
| Feb 27, 2026 | JANNEY DANIELDirector | Sale | 9,430 | $2.60M | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4